Pharmaceutical Pricing Does Federal R&D Support Justify Federal Review of Prices?

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Business.

Drugs.

Pharmaceutical industry.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Washington, D.C.] [publisher not identified] 1993

Summary:

Explores arguments for price regulation of drugs developed with Federal aid in the form of R&D support or technology transfers. Reviews efforts to moderate the prices of these pharmaceuticals through Congressional action and "price clause" enforcement by the NIH's Patent Policy Board. Examines relevant statutes and regulations, legislative history, and pharmaceutical industry's viewpoint

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Pharmaceutical Pricing

Publisher Number:

CRS-1993-ECN-0122

Access Restriction:

Restricted for use by site license